Amado Rafael

Related Filers (4)

Other (1)

144
Tuesday, 1/2/2024
Filing for proposed sale of securities under Rule 144
Show More

Ownership (31)

4
Wednesday, 1/3/2024
Zai Lab Ltd: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/2/2023
Poseida Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 4/14/2023
Poseida Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 4/5/2023
Zai Lab Ltd: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/3/2023
Zai Lab Ltd: Initial statement of beneficial ownership of securities
4
Tuesday, 1/3/2023
Zai Lab Ltd: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/11/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/5/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/2/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/6/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/22/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/19/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/25/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/17/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/4/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/30/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/17/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/2/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/20/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/5/2019
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/5/2019
Allogene Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/7/2019
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/16/2019
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/8/2019
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/7/2018
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/17/2018
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/18/2017
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/20/2016
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
3
Monday, 1/4/2016
Adaptimmune Therapeutics PLC: Initial statement of beneficial ownership of securities
Show More